Predicting cognitive trajectories in asymptomatic individuals at‐risk of AD: insights from a multi‐platform plasma proteomics study

Abstract

Background: Plasma biomarkers enabling early detection of Alzheimer's disease (AD) biological hallmarks are now available. Yet, predicting cognitive decline in at‐risk individuals remains challenging due to the high variability of cognitive outcomes and lack of reliable prognostic markers.